Looking Anew at Alzheimer’s Disease
May 8, 2019
Following the failure of several experimental drugs thought promising for treating Alzheimer’s disease, scientists are by necessity expanding their search for therapeutic candidates. Issues recently took a deep look at the challenges, with a science policy analyst recounting his history of following Alzheimer’s research and treatment—where it has failed and where it has advanced—and the head of a private foundation long involved in the field citing the need to “ask the right questions” in pursing new directions in aging and neurodegeneration research.